A future for regulatory science in the European Union: the European Medicines Agency’s strategy

The European Medicines Agency facilitates access to medicines in low- and middle-income countries

Pregnant women should not take ibuprofen after 20 weeks, FDA says. It could harm the baby's kidneys.

Prescribing Proton Pump Inhibitors need paradigm shift in the practice

Transparencia para evitar el lobby farmacéutico: participación ciudadana y medicamentos esenciales

Detectadas trazas de contaminantes procedentes de plásticos, detergentes y medicamentos en los cereales

Los alimentos que nunca se deben mezclar con las medicinas

Anvisa alerta sobre falsificação de medicamentos

FDA recommends avoiding use of NSAIDs in pregnancy at 20 weeks or later because they can result in low amniotic fluid

Cofepris alertó por robo de más de 10,000 dosis de vacuna contra la influenza

Case study: the incorrect DAA

Over 1M fake medicines detained in 2019

El Remdesivir no reduce la mortalidad del coronavirus, según la OMS

Sanidad retira 38 lotes de Pankreoflat por no advertir de posibles reacciones adversas

La Guardia Civil denuncia en Zaragoza los medicamentos veterinarios que vendían como “fórmula magistral”

Postapproval Vaccine Safety Surveillance for COVID-19 Vaccines in the US

Minsa retira la azitromicina, ivermectina e hidroxicloroquina del tratamiento contra el COVID-19

Evaluation of a pharmacist-led actionable audit and feedback intervention for improving medication safety in UK primary care: An interrupted time series analysis

Considerations for pharmacoepidemiological analyses in theSARS-CoV-2 pandemic

How to optimize the pharma supply chain to aid smooth delivery of COVID-19 vaccines

AEMPS: "Cuando la vacuna para el coronavirus llegue, comenzará un esfuerzo sin precedentes en farmacovigilancia"

Las 8 situaciones en las que no deberías tomar una aspirina

Cuatro perfiles sanitarios revisarán el sistema de precios de fármacos

Medicines substitutions in supermarket home deliveries put customers at risk, RPS warns

La FDA halla negligencias en la planta de Lilly que prepara un fármaco anti-COVID

Researchers are taking aim at the counterfeit drug and medical supplies market

Coepris alerta sobre la comercialización ilegal de vacuna Vaxigrip

Gemán Málaga: "Estos medicamentos generan una falsa sensación de seguridad"

Negligencias "muy graves" de la farmacéutica Lilly paralizan la autorización de un medicamento anti covid

La compañía Lilly frena “por seguridad” los ensayos del fármaco para la Covid que elogió Trump

International Collaboration in Real-World Evidence Generation for Direct Acting Oral Anti-Coagulants

Daylight Savings linked to increased medical errors

Medication use among older people in Europe: Implications for regulatory assessment and co‐prescription of new medicines

Regulatory review of the environmental risk assessment of veterinary medicinal products in the European Union, with particular focus on the centralised authorisation procedure

Clinical trial publications: A sufficient basis for healthcare decisions?

Rubros más afectados por el comercio ilícito y contrabando

Clinical Trials for COVID‐19: Can we Better Use the Short Window of Opportunity?

An Application of Machine Learning in Pharmacovigilance: Estimating Likely Patient Genotype From Phenotypical Manifestations of Fluoropyrimidine Toxicity

RPS calls for prevention of counterfeit medicines in UK’s supply chain

A future for regulatory science in the European Union: the European Medicines Agency’s strategy